首页> 美国卫生研究院文献>Springer Open Choice >Allergic contact dermatitis: epidemiology molecular mechanisms in vitro methods and regulatory aspects
【2h】

Allergic contact dermatitis: epidemiology molecular mechanisms in vitro methods and regulatory aspects

机译:过敏性接触性皮炎:流行病学分子机制体外方法和调节方面

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Contact allergies are complex diseases, and one of the important challenges for public health and immunology. The German ‘Federal Institute for Risk Assessment’ hosted an ‘International Workshop on Contact Dermatitis’. The scope of the workshop was to discuss new discoveries and developments in the field of contact dermatitis. This included the epidemiology and molecular biology of contact allergy, as well as the development of new in vitro methods. Furthermore, it considered regulatory aspects aiming to reduce exposure to contact sensitisers. An estimated 15–20% of the general population suffers from contact allergy. Workplace exposure, age, sex, use of consumer products and genetic predispositions were identified as the most important risk factors. Research highlights included: advances in understanding of immune responses to contact sensitisers, the importance of autoxidation or enzyme-mediated oxidation for the activation of chemicals, the mechanisms through which hapten-protein conjugates are formed and the development of novel in vitro strategies for the identification of skin-sensitising chemicals. Dendritic cell cultures and structure-activity relationships are being developed to identify potential contact allergens. However, the local lymph node assay (LLNA) presently remains the validated method of choice for hazard identification and characterisation. At the workshop the use of the LLNA for regulatory purposes and for quantitative risk assessment was also discussed.
机译:接触过敏是复杂的疾病,是公共卫生和免疫学的重要挑战之一。德国“联邦风险评估研究所”举办了“接触性皮炎国际研讨会”。研讨会的范围是讨论接触性皮炎领域的新发现和发展。这包括接触过敏的流行病学和分子生物学,以及新的体外方法的发展。此外,它考虑了旨在减少接触敏化剂暴露的监管方面。估计总人口的15–20%患有接触性过敏。工作场所的暴露,年龄,性别,消费产品的使用和遗传易感性被确定为最重要的危险因素。研究重点包括:对接触敏化剂的免疫反应的了解,自氧化或酶介导的氧化对于化学物质活化的重要性,半抗原-蛋白质结合物形成的机理以及鉴定新的体外策略的进展对皮肤敏感的化学物质。正在开发树突状细胞培养物和结构-活性关系以鉴定潜在的接触过敏原。然而,局部淋巴结测定(LLNA)目前仍然是危险性鉴定和表征的有效选择方法。在研讨会上,还讨论了将LLNA用于监管目的和定量风险评估的方法。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号